Driving Decision Aid for Vision Impairment

N/A
Waitlist Available
Led By Marian E Betz, MD, MPH
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least one medical condition linked in driving cessation
5-minute MoCA score greater or equal to 21
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up6 months, 12 months, 18 months, 24 months
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will test a driving decision aid to help older adults make decisions about driving. It will assess the impact of the aid on the quality of decisions and on specific subgroups of older drivers.

Eligible Conditions
  • Vision Impairment
  • Arthritis
  • Traumatic Brain Injury
  • Restless Legs Syndrome
  • Chronic Obstructive Pulmonary Disease
  • Parkinson's Disease
  • Orthostatic Hypotension
  • Narcolepsy
  • Multiple Sclerosis
  • Dizziness
  • Type 1 Diabetes
  • Foot Abnormalities
  • Insomnia
  • Congestive Heart Failure
  • ICD User
  • Hypertrophic Cardiomyopathy
  • Obstructive Sleep Apnea
  • Spinal Cord Injury
  • Sleep Apnea
  • Fainting
  • Vertigo
  • Stroke
  • Diabetic Retinopathy
  • Retinitis Pigmentosa
  • Acute Coronary Syndrome
  • Glaucoma
  • Seizures
  • Age-Related Macular Degeneration
  • Kidney Failure
  • Substance Abuse
  • Dementia

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
You have a medical condition that affects your ability to drive safely.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months, 12 months, 18 months, 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months, 12 months, 18 months, 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decisional Conflict Scale (DCS) Scores at Day 0 (Post-intervention)
Secondary outcome measures
Change in Life Space score
Change in Ottawa Decision Regret score
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) 4-item depression score
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Driving Decision AidExperimental Treatment1 Intervention
Web-based Driving Decision Aid
Group II: Older Drivers WebsiteActive Control1 Intervention
National Institute on Aging (NIA) Older Drivers website

Find a site

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,672 Previous Clinical Trials
1,661,681 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,556 Previous Clinical Trials
5,300,067 Total Patients Enrolled
Marian E Betz, MD, MPHPrincipal Investigator
University of Colorado - Anschutz Medical Campus

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process for this research initiative still open?

"This clinical trial is, as indicated by its presence on clinicialtrials.gov, not currently seeking enrolment. The investigation was first posted 12/12/2019 and last updated on 10/6/2022. Despite this particular study's hiatus from recruiting patients, there are 8150 other trials actively accepting participants at the moment."

Answered by AI

Who else is applying?

What state do they live in?
Florida
California
What portion of applicants met pre-screening criteria?
Did not meet criteria
What site did they apply to?
University of California, San Diego
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I have very bad arthritis throughout my body.
Patient

What questions have other patients asked about this trial?

How much does it pay?
Patient
Recent research and studies
~112 spots leftby Oct 2024